Disable ads (and more) with a premium pass for a one time $4.99 payment
Mobic (meloxicam) and Tylenol (acetaminophen) are both medications used to relieve pain, but they have different mechanisms and effects on the body. The correct choice here highlights that these medications do not interfere with platelet function.
Mobic is a non-steroidal anti-inflammatory drug (NSAID) that can inhibit platelet aggregation due to its effects on the cyclooxygenase (COX) enzymes; however, it does not have as significant an effect on platelet function as other NSAIDs, such as aspirin. Tylenol, on the other hand, has a different mechanism of action and does not have a meaningful impact on platelet aggregation at therapeutic doses.
In contrast, other options like blood pressure regulation may be influenced by Mobic, as it can potentially cause fluid retention and hypertension in susceptible individuals. Pain perception is the primary effect of these medications, and both drugs are used specifically to manage pain. Finally, kidney function can be affected by long-term or high-dose use of Mobic, as NSAIDs can lead to kidney impairment in some cases.
Thus, recognizing that Mobic and Tylenol do not significantly impact platelet function is crucial to understand their safe use, especially for patients who may be at risk